Characterization of a dual BET/HDAC inhibitor for treatment of pancreatic ductal adenocarcinoma. - Zhang X; Zegar T; Weiser T; Hamdan FH; Berger BT; Lucas R; Balourdas DI; Ladigan S; Cheung PF; Liffers ST; Trajkovic-Arsic M; Scheffler B; et al. (International journal of cancer, 2020)